CDC Logo Tuberculosis Information CD-ROM   Image of people
     
jump over main navigation bar to content area
Home
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Newsletters
Ordering Information
Help

 

U.S. Department of Health and Human Services

  

TB Facts for Health Care Workers

Multidrug-Resistant Tuberculosis (MDR TB)

An extremely serious aspect of the TB problem in the United States is MDR TB (i.e., TB resistant to at least isoniazid and rifampin). MDR TB can usually be prevented by initially treating TB patients with four drugs and by administering TB medications on a directly observed basis. Persons at high risk for MDR TB include persons who have been recently exposed to MDR TB, especially if they are immunocompromised; TB patients who failed to take medications as prescribed; TB patients who were prescribed an ineffective treatment regimen; and persons previously treated for TB.

MDR TB presents difficult treatment problems. Treatment must be individualized and based on the patientís medication history and drug susceptibility study results. Clinicians who are not familiar with the management of patients with MDR TB disease or with patients infected with multidrug-resistant organisms should seek expert consultation. 

For persons likely to have been infected with M. tuberculosis resistant to both isoniazid and rifampin, observation without preventive therapy is usually recommended because only isoniazid and rifampin have been evaluated for preventive therapy. However, for persons at an especially high risk for TB disease once infected (e.g., persons with HIV infection), preventive therapy with an alternative regimen should be strongly considered.

 

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333